StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial – Gains in Sensory Function Persist 12 Months After Stem Cell Transplant

StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial – Gains in Sensory Function Persist 12 Months After Stem Cell Transplant

[at noodls] – Improvement From Complete to Incomplete Injury Observed in One Patient NEWARK, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced that the twelve-month data from the … more

View todays social media effects on STEM

View the latest stocks trending across Twitter. Click to view dashboard

See who StemCells is hiring next, click here to view

Share this post